Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03157297 · ClinicalTrials.gov registry record · Phase 1
Micra Atrial Tracking Using a Ventricular Accelerometer Study
A Phase 1 study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT03157297 is a Phase 1 study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 70 participants.
The verdict
NCT03157297, a Phase 1 study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize performance of the MARVEL algorithm downloaded into the MicraTM TPS to provide atrial synchronous ventricular pacing in subjects with AV block. A sub-study will be conducted within the Marvel study, the purpose of this study is to characterize the MARVEL algorithm in patients who were enrolled in the MARVEL study, and to collect and compare the accelerometer signals and AV synchrony at a second point in time.
Interventions
- DEVICE MARVEL algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2017-11-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03157297
The ClinicalTrials.gov registry entry for NCT03157297 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MARVEL algorithm is the first listed.
NCT03157297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03157297 about?
NCT03157297 is a clinical study titled "Micra Atrial Tracking Using a Ventricular Accelerometer Study". The purpose of this study is to characterize performance of the MARVEL algorithm downloaded into the MicraTM TPS to provide atrial synchronous ventricular pacing in subjects with AV block. A sub-study will be conducted within the Marvel study, the purpose of this study is to characterize the MARVEL...
What is the current status of trial NCT03157297?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2017-07-10. Estimated completion is 2017-11-24.
What interventions are being tested in trial NCT03157297?
The interventions under investigation include: MARVEL algorithm (DEVICE).
Who is sponsoring clinical trial NCT03157297?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.